- Preview Available
- Scholarly Journal
Empagliflozin-based quadruple oral therapy for type 2 diabetes: a prospective cohort study
Scientific Reports (Nature Publisher Group); London Vol. 15, Iss. 1, (2025): 1427.
DOI:10.1038/s41598-024-84993-x
This is a limited preview of the full PDF
Try and log in through your library or institution to see if they have access.